跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
(4-fluorophenyl)(pyridin-4-yl)methanone
首页
药物
(4-fluorophenyl)(pyridin-4-yl)methanone
Experimental
Small Molecule
(4-fluorophenyl)(pyridin-4-yl)methanone
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
12
H
8
FNO
UNII ID
J88AAY34QE
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
FORMULATIONS OF GLUCOCORTICOID RECEPTOR MODULATORS
申请人: CORCEPT THERAPEUTICS INC
优先权: 2022
CN
EP
US
WO
6 件公开
THERAPEUTIC USES OF RELACORILANT, A HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATOR
申请人: CORCEPT THERAPEUTICS INC
优先权: 2019
CN
EP
US
WO
12 件公开
PHARMACEUTICAL FORMULATIONS CONTAINING RELACORILANT, A HETEROARYL-KETONE FUSED AZADECALIN COMPOUND
申请人: CORCEPT THERAPEUTICS INC
优先权: 2018
CN
EP
US
WO
11 件公开
METHODS OF TREATING PROSTATE CANCER USING EXICORILANT AND ENZALUTAMIDE
申请人: CORCEPT THERAPEUTICS INC
优先权: 2022
EP
US
WO
3 件公开
TREATMENTS FOR AMYOTROPHIC LATERAL SCLEROSIS USING DAZUCORILANT
申请人: CORCEPT THERAPEUTICS INC
优先权: 2022
CN
EP
US
WO
5 件公开
Treatment of Cushing's syndrome without significant impact on cardiac rhythm
申请人: CORCEPT THERAPEUTICS INC
优先权: 2022
CN
Methods of treating adrenal tumor
申请人: CORCEPT THERAPEUTICS INC
优先权: 2023
CN
TREATMENTS FOR AMYOTROPHIC LATERAL SCLEROSIS USING DAZUCORILANT
申请人: CORCEPT THERAPEUTICS INC
优先权: 2025
US
药物
反馈
